Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, December 2009

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 416 Dimensions

Readers on

mendeley: 172 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHOD FOR DETERMINING THE RISK OF TOXICITY OF SORAFENIB IN CANCER PATIENTS

Application WO-2013174637-A1

World Intellectual Property Organisation (WIPO)